×

Can Allergan Rejuvenate Your Portfolio?

Allergan's sales increased in almost all segments with eye care up 3.9 percent, Botox up 6.6 percent, skin care up a whopping 31.3 percent, breast aesthetics up 14 percent, and facial aesthetics up 35 percent.

On a terrible day we've got a rocking good stock, and Cramer talks about it with Allergan CEO David Pyott in the video below.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com